Breaking

Saturday, 4 April 2020

Monash Biomedicine Discovered Cure For Corona Virus

The deadly corona virus has spread around the world, sending billions of people into lockdown as scientists researching for the cure, while, health services struggle to cope with the new frustrating cases on daily bases. 

Medical experts, health organizations and concerned indivaduals are finding out where the virus has spread, and where it has been most deadly, through the media, internet and report.




Global Coronavirus Cases:
1,202,589

Deaths
64,732

Recovered
246,640

The coronavirus COVID-19 is affecting 206 countries and territories around the world and 2 international conveyances.


However, scientist around the world are working tiredlessly to profer a cure to the novel corona virus, Ivermectin drench gives us hope as Covid-19 cure.

A common parasitic drench may hold the antidote to COVID-19, currently gripping the world.

The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and clinical trials, with funding urgently required to progress the work.

A collaborative study led by Monash University's Biomedicine Discovery Institute (BDI) in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.

The Monash Biomedicine Discovery Institute's Dr Kylie Wagstaff, who led the study, said the scientists showed that the drug, Ivermectin, stopped the SARS-CoV-2 virus growing in cell culture within 48 hours.

"We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," Dr Wagstaff said.

Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, Dengue, Influenza and Zika virus.

Dr Wagstaff cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people.

"Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective - that's the next step," Dr Wagstaff said.

"In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner.

Realistically it's going to be a while before a vaccine is broadly available.


Although the mechanism by which Ivermectin works on the virus is not known, it is likely, based on its action in other viruses, that it works to stop the virus 'dampening down' the host cells' ability to clear it, Dr Wagstaff said.


The use of Ivermectin to combat COVID-19 would depend on the results of further pre-clinical testing and ultimately clinical trials, with funding urgently required to keep progressing the work, Dr Wagstaff said.



No comments:

Post a Comment